Concomitant irritable bowel syndrome is associated with failure of step-down on-demand proton pump inhibitor treatment in patients with gastro-esophageal reflux disease
Justin C. Y. Wu(Chinese University of Hong Kong), Francis K.L. Chan(Christian Health Association of Nigeria), Lee‐Lun Lai(KTH Royal Institute of Technology), Joseph J.�Y. Sung(Chinese University of Hong Kong), Grace Lai‐Hung Wong(Chinese University of Hong Kong), Dorothy K. Chow(Chinese University of Hong Kong)
Cited by 28
Related Papers
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.7k
ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
|Circulation|2008|845
Screening for gastric cancer in Asia: current evidence and practice
|The Lancet Oncology|2008|830
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients
|Proceedings of the National Academy of Sciences|2015|755